Charles Woler

Charles Woler founded Neuro3D SA in 2000, where he worked as President & Chief Executive Officer in 2007 and Inflamalps SA in 2012, where he worked as Chairman.
Dr. Woler also currently works at Biomnis SELAS, as Chairman-Supervisory Board & CEO from 2014, Groupe Proclif SAS, as Chairman from 2010, Deinove SA, as Chairman from 2017, Biods, as Chairman, OCON Medical Ltd., as Chairman, Upperton Ltd., as Chairman, MedTrade Products Ltd., as Director from 2019, Atlantic Healthcare Plc, as Non-Executive Director, Optimapharm doo, as Member-Supervisory Board, and W Finance & Strategy SARL, as Manager.
Dr. Woler also formerly worked at Cadus Corp., as Chief Executive Officer from 1995 to 1998, Endotis Pharma SARL, as Chairman & Chief Executive Officer from 2009 to 2013, Ridoret Distribution SARL, as Chairman & Chief Executive Officer, Smithkline Beecham Plc, as Chairman-Pharmaceuticals Europe Region, Synexus Clinical Research Ltd., as Chairman, Citoxlab France SAS, as Chairman, Genfit SA, as Vice Chairman-Supervisory Board from 2014 to 2017, France Biotech Association, as Executive Vice Chairman from 2004 to 2007, ImClone LLC, as Director from 2006 to 2008, Hemosystem SA, as Director, Rose Pharma A, as Director from 2009 to 2010, Fore Biotherapeutics, Inc., as Director, Duke Street LLP, as Operating Partner from 2005 to 2013, Bouchara SAS, as General Manager, and Travecta Therapeutics Pte Ltd., as Advisor.
Dr. Woler received his Masters Business Admin degree and doctorate degree from Université Paris 1 Panthéon-Sorbonne and doctorate degree from the University of Lyon.